• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER DUCT OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER DUCT OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Hemolysis (1886); Thrombosis (2100); Loss Of Pulse (2562)
Event Date 09/29/2020
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in the final report.
 
Event Description
The article "comparison of isolated venous approach with the standard approach in children undergoing patent ductus arteriosus device closure" published on 29 september, 2020 was reviewed.This research article is a prospective single center experience to compare the two vascular approaches of pda device closure in pediatric patients and have also studied the feasibility of this approach in young children with weight < 6 kg.Amplatzer duct occluder (ado), cocoon duct occluder, lifetech duct occluder were associated to the study.There is no allegation of malfunction of the abbott device.The article concluded that the isolated venous approach is a pragmatic approach for pda device closure.The primary author of the article is lipi uppal, md of department of cardiology, post graduate institute of medical education and research, chandigarh, india with the email cardiopgimerchd@gmail.Com.
 
Manufacturer Narrative
As reported in a research article, complications of device placement for patent ductus arteriosus closure included hematoma, thrombosis, transient loss of pulse, and hemolysis.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER DUCT OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key10881980
MDR Text Key217675684
Report Number2135147-2020-00507
Device Sequence Number1
Product Code MAE
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup
Report Date 12/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/22/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received12/16/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age52 YR
Patient Weight17
-
-